Publications by authors named "Naka N"

: Proximal junctional kyphosis (PJK) and failure (PJF), the most prevalent complications following long-segment thoracolumbar fusions for adult spinal deformity (ASD), remain lacking in defined preventive measures. We studied whether one of the previously reported strategies with successful results-a prophylactic augmentation of the uppermost instrumented vertebra (UIV) and supra-adjacent vertebra to the UIV (UIV + 1) with polymethylmethacrylate (PMMA)-could also serve as a preventive measure of PJK/PJF in minimally invasive surgery (MIS). : The study included 29 ASD patients who underwent a combination of minimally invasive lateral lumbar interbody fusion (MIS-LLIF) at L1-2 through L4-5, all-pedicle-screw instrumentation from the lower thoracic spine to the sacrum, S2-alar-iliac fixation, and two-level balloon-assisted PMMA vertebroplasty at the UIV and UIV + 1.

View Article and Find Full Text PDF

Ultrafine splittings are found in the optical absorption spectra of boron-doped diamond measured with high resolution. An analytical model of an exciton complex is developed, which permits assigning all absorption lines and sizing the interactions among the constituent charges and crystal field. We conclude that the entry of split-off holes in the acceptor-bound exciton fine structure yields two triplets separated by a spin-orbit splitting of 14.

View Article and Find Full Text PDF

Objective: The efficacy of anterior column realignment (ACR) remains relatively unclear, possibly because some safety concerns have limited its adoption and extensive evaluation. The authors aimed to study whether a minimally invasive surgery (MIS) triad consisting of ACR, lateral lumbar interbody fusion, and percutaneous pedicle screw fixation in a select group of adult spinal deformity (ASD) patients helps shorten fusion length without compromising clinical and radiographic outcomes over a minimum 2-year follow-up period.

Methods: A series of 61 ASD patients (mean age 72.

View Article and Find Full Text PDF

No standard treatment has been established for most rare cancers. Here, we report a clinical trial of a biweekly WT1 tri-peptide-based vaccine for recurrent or advanced rare cancers. Due to the insufficient number of patients available for a traditional clinical trial, the trial was designed for rare cancers expressing shared target molecule WT1.

View Article and Find Full Text PDF
Article Synopsis
  • - The guidelines aim to provide evidence-based recommendations for improving the diagnosis, treatment, and prognosis of patients with soft tissue tumors.
  • - A multidisciplinary team created 22 clinical questions (CQs) and developed guidelines based on systematic reviews of evidence and expert input, following specific development methods.
  • - The recommendations are designed to help healthcare professionals make better decisions in treating soft tissue tumors, ultimately enhancing patient care in this area.
View Article and Find Full Text PDF

The Wilms' tumor gene WT1 is highly expressed in various malignancies and may be a common target antigen for cancer immunotherapy. In our group, peptide-based cancer vaccines targeting WT1 CTL epitopes were developed as an immunotherapy for these malignancies. In the present study, WT1 epitope-specific immune responses were analyzed in 31 patients with advanced sarcoma with human leukocyte antigen-A*24:02- and WT1-expressing tumors who received the WT1-235 peptide vaccine as monotherapy.

View Article and Find Full Text PDF

Objectives: Metastasectomy is often the local treatment for pulmonary metastases arising from osteosarcoma or soft tissue sarcoma. However, there have been few investigations on the outcomes of patients who undergo this procedure. In this study, we identified prognostic factors in patients with pulmonary metastases arising from osteosarcoma and soft tissue sarcoma to determine more appropriate eligibility criteria for metastasectomy.

View Article and Find Full Text PDF

We demonstrate that broadband sum frequency generation (SFG) spectroscopy based on a partially incoherent supercontinuum light source can elucidate dark p-series excitons in monolayer WSe encapsulated between hexagonal boron nitride (hBN) slabs. The observed 2p exciton peak energy is a few meV higher than that predicted by the Rytova-Keldysh potential model, which is originated from the Berry phase effect. Interestingly, although the radiative relaxation of the 2p exciton is weaker, the 2p exciton peak is broader than the 1s and 2s peaks, which indicates its faster dephasing than the 1s and 2s excitons.

View Article and Find Full Text PDF

We elucidated clinicopathological characteristics of giant cell tumor of bone (GCTB) in Japan, and significant clinicopathological factors for predicting local recurrence. Clinicopathological profiles of 213 patients with GCTB (100 male, 113 female) involving extra-craniofacial bones were retrieved. Pathological slides obtained at the initial surgery were reviewed.

View Article and Find Full Text PDF

Background osteosarcoma is a rare, primary malignant bone tumour with limited available treatments for advanced or recurrent disease, resulting in a poor prognosis for patients. TAS-115 is a novel tyrosine kinase inhibitor under investigation in a phase I study in patients with solid tumours. We report data of osteosarcoma patients in the expansion cohort of this ongoing study.

View Article and Find Full Text PDF

Previous studies have not clearly identified a prognostic factor for desmoid tumours (DT). Whole-exome sequencing (WES) and/or RNA sequencing (RNA-seq) were performed in 64 cases of DT to investigate the molecular profiles in combination with the clinicopathological characteristics. CTNNB1 mutations with specific hotspots were identified in 56 cases (87.

View Article and Find Full Text PDF
Article Synopsis
  • This study explored the clinical outcomes of 43 patients with bone sarcomas who underwent unplanned surgeries across 23 hospitals in Japan from 2006 to 2017, focusing on patterns and results.
  • The majority of patients had osteosarcoma or Ewing sarcoma, with common primary tumor locations being the femur and spine; unplanned procedures included curettage and surgical resections, often accompanied by additional treatments.
  • The 5-year disease-specific survival rates varied by tumor type, with a significant decrease in survival for patients who experienced local recurrences compared to those who did not.
View Article and Find Full Text PDF

We describe the stress analysis of silicon oxide (SiO) thin film using cathodoluminescence (CL) spectroscopy and discuss its availability in this paper. To directly measure the CL spectra of the film under uniaxial tensile stresses, specially developed uniaxial tensile test equipment is used in a scanning electron microscope (SEM) equipped with a CL system. As tensile stress increases, the peak position and intensity proportionally increase.

View Article and Find Full Text PDF
Article Synopsis
  • Angiosarcoma (AS) is a rare and aggressive tumor, especially when linked to chronic lymphedema, termed Stewart-Treves syndrome (STS), which is very rare in the lower abdominal wall.
  • A 76-year-old woman with STS developed after previous cervical cancer treatment showed significant improvement after receiving eribulin, a microtubule inhibitor approved for soft tissue sarcoma in Japan.
  • Following her treatment with eribulin, the patient experienced a notable reduction in tumor size with stable lesions and minimal side effects, suggesting that eribulin could be a promising option for STS therapy.
View Article and Find Full Text PDF

The number of studies on bone metastasis (BM) from gastric cancer (GC) is currently limited. Therefore, the aim of the present study was to investigate the characteristics, skeletal-related events (SREs) and prognosis of GC in patients with BMs. Data from 60 patients with BMs from GC were retrospectively retrieved and patient-, tumor- and BM-related characteristics were analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on the effectiveness of pazopanib for treating malignant peripheral nerve sheath tumors (MPNST), which are typically unresponsive to chemotherapy and associated with NF1.
  • A phase II clinical trial included 12 patients, with outcomes measured at 12 weeks using clinical benefit rate (CBR), progression-free survival (PFS), and overall survival (OS).
  • Findings showed a 50% CBR, median PFS of 5.4 months, and median OS of 10.6 months, indicating that pazopanib could be a safe and more effective treatment option than previous therapies for MPNST.
View Article and Find Full Text PDF

The aim of this study was to evaluate the anti-anaphylactic and anti-allergic potentials of saracatinib, a Src family kinase inhibitor that was already shown to be safe in clinical trials when it was used as an anti-cancer drug. Using mast cell models, we found that saracatinib inhibited the degranulation response and cytokine production in RBL2H3 cells that were stimulated with IgE and antigen without affecting cell viability. Phosphorylation of Lyn, Akt, a PI3K substrate, and MAPKs including ERK, JNK, and p38, as well as the intracellular Ca increase induced by this stimulation were also suppressed by saracatinib.

View Article and Find Full Text PDF

Alveolar soft part sarcoma (ASPS), epithelioid sarcoma (ES), and clear cell sarcoma (CCS) are known to be chemoresistant tumors. The aim of this study was to investigate the effect of pazopanib on these chemoresistant tumors. This study is designed as a single-arm, multicenter, investigator-initiated phase II trial.

View Article and Find Full Text PDF

Objectives: It is challenging to know at the first which patients with desmoid fibromatosis (DF) are better suited to conservative or aggressive treatment. To investigate whether the low signal intensity bundles on T1- or T2-weighted images (WI), termed the "black fiber sign (BFS)," can predict non-progressive behavior in the conservative approach.

Methods: This retrospective study included 59 patients with primary DF managed with wait-and-see approach from 2005 to 2018 and serial MR images were analyzed.

View Article and Find Full Text PDF

Methods: We retrospectively reviewed 33 patients who underwent osteoarticular ECIA after bone tumor resection from 1988 to 2014. We investigated complications, radiographic changes by the International Society of Limb Salvage graft evaluation criteria, and functional outcomes according to the Musculoskeletal Tumor Society scoring system.

Results: Fifteen patients were reoperated upon due to infection ( = 9), protruding fixation implant ( = 4), or fracture of the grafted bone ( = 2).

View Article and Find Full Text PDF

Background And Objectives: The aim of this study is to assess the survival, function, radiographic appearance, and modes of failure of extracorporeal irradiated (ECI) autografts in a long-term setting.

Methods: We retrospectively reviewed 87 patients who were treated for bone and soft tissue tumors using ECI autografts between 1988 and 2009.

Results: The 56 patients had a minimum follow-up of 10 years, and the median follow-up period was 16.

View Article and Find Full Text PDF

Front face fluorescence spectroscopy of typical Japanese soil powders (soil A: Typic Hapludand; soil H: Typic Hydraquent; soil Y: Typic Paleudult) has been conducted. Three dimensional excitation-emission matrix fluorescence spectra of the 100 wt% soils showed similar fluorescence patterns to each other. The fluorescence patterns were similar between the soil samples and their residues after extraction by NaOH solution for 60 min.

View Article and Find Full Text PDF
Article Synopsis
  • * TAS-115 is a new drug that targets multiple receptor tyrosine kinases and is being tested in clinical trials, showing promise in slowing tumor growth and lung metastasis in mouse models of osteosarcoma.
  • * The research indicates that TAS-115 works by inhibiting specific signaling pathways related to tumor growth, which are also active in human osteosarcoma cell lines, making it a potential new treatment option.
View Article and Find Full Text PDF

Background: Chondroblastoma (CB) is a rare locally aggressive bone tumor that commonly occurs in the epiphysis or apophysis of long bones. Although surgical treatment of CB carries potential risk for physeal or articular cartilage damage, risk factors for joint degeneration have not been well described. In addition, we have mainly used synthetic bone substitute (SBS) to fill the bone defect after intralesional curettage as treatment for CB.

View Article and Find Full Text PDF

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

View Article and Find Full Text PDF